Medius Holdings Co., Ltd. (3154) AI Stock Analysis

• Market Cap: ¥18.79B
• Dividend Yield: 2.35%
• Average Volume (3M): 26.54K
• Price to Earnings (P/E): 13.6
• Beta (1Y): 0.58
• Revenue Growth: 11.12%
• EPS Growth: 20.54%
• Country: JP
• Employees: 2,517
• Sector: Healthcare
• Sector Strength: 53
• Industry: Medical - Instruments & Supplies
• EPS (TTM): 0.19
• Shares Outstanding: 22,238,216
• 10 Day Avg. Volume: 18,310
• 30 Day Avg. Volume: 26,540
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): N/A
• P/FCF Ratio: N/A
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: ¥869.00
• Price Target Upside: 2.00% Upside
• Rating Consensus: Hold
• Number of Analyst Covering: 0

• Rating: 60 Neutral
• Price Target: ¥869.00 ▲(2.00% Upside)

The overall stock score of 60 reflects a balanced view of Medius Holdings Co., Ltd. The company's strong financial performance is offset by technical indicators pointing to bearish momentum. The reasonable valuation and attractive dividend yield provide some support, but the increased leverage and cash flow volatility are potential risks that need to be addressed.

Medius Holdings Co., Ltd. Business Overview & Revenue Model

Company Description

Medius Holdings Co., Ltd. (3154) is a Japan-based company primarily engaged in the wholesale sector, focusing on medical products and healthcare services. The company offers a broad range of medical supplies, equipment, and related services to healthcare institutions, clinics, and other medical facilities. Medius Holdings aims to support the healthcare industry by providing high-quality products and innovative solutions that enhance patient care and operational efficiency.

How the Company Makes Money

Medius Holdings Co., Ltd. generates revenue through the wholesale distribution of medical supplies and equipment to various healthcare providers and institutions. The company's key revenue streams include the sale of consumable medical products, surgical instruments, and diagnostic devices. Additionally, Medius Holdings may engage in partnerships with medical manufacturers to distribute exclusive products, enhancing its market presence and competitiveness. The company benefits from long-term contracts with hospitals and clinics, ensuring a steady income flow and fostering strong customer relationships. These factors, along with the growing demand for healthcare services, contribute significantly to the company's earnings.

Medius Holdings Co., Ltd. Financial Statement Overview

Summary

Medius Holdings Co., Ltd. demonstrates strong revenue growth and stable profitability margins. The balance sheet is solid with adequate leverage, though cash flow variations require attention.

Income Statement

Medius Holdings Co., Ltd. shows a strong revenue growth trajectory with recent TTM data indicating a rise in total revenue. The gross profit margin is stable, reflecting efficient cost management. However, the net profit margin has shown some volatility, which could be a concern. EBIT and EBITDA margins are consistent, suggesting operational stability.

Balance Sheet

The company's balance sheet reveals a moderate debt-to-equity ratio, indicating a balanced approach to leverage. The return on equity is healthy, demonstrating effective utilization of shareholder funds. The equity ratio is satisfactory, reflecting a solid asset base supported by equity.

Cash Flow

Cash flow analysis shows fluctuations in free cash flow, influenced by capital expenditure dynamics. Despite operating cash flow being zero in the latest TTM data, previous periods have shown positive cash flow generation. The company needs to focus on sustaining free cash flow for long-term stability.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	286.18B	288.69B	259.79B	239.05B	221.69B	246.79B
Gross Profit	33.60B	33.30B	31.09B	29.31B	27.42B	25.20B
EBITDA	4.44B	4.77B	3.86B	4.27B	3.80B	4.14B
Net Income	1.35B	1.38B	1.12B	1.50B	1.87B	2.07B
Balance Sheet
Total Assets	123.52B	113.02B	114.83B	97.46B	92.95B	84.44B
Cash, Cash Equivalents and Short-Term Investments	16.13B	14.33B	13.66B	10.36B	9.15B	12.67B
Total Debt	24.26B	21.24B	24.17B	19.57B	17.82B	11.60B
Total Liabilities	102.87B	92.55B	95.09B	78.88B	75.65B	68.59B
Stockholders Equity	20.65B	20.48B	19.74B	18.57B	17.31B	15.84B
Cash Flow
Free Cash Flow	0.00	5.26B	261.12M	300.65M	-8.49B	2.93B
Operating Cash Flow	0.00	7.01B	1.92B	1.22B	-3.90B	6.85B
Investing Cash Flow	0.00	-2.51B	-2.67B	-862.94M	-4.82B	-4.62B
Financing Cash Flow	0.00	-3.47B	4.01B	862.90M	5.21B	1.90B

Medius Holdings Co., Ltd. Technical Analysis

• Technical Analysis Sentiment: Neutral
• Last Price: 852.00
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:3154, the sentiment is Neutral. The current price of 852 is above the 20-day moving average (MA) of 849.00, below the 50-day MA of 861.76, and below the 200-day MA of 875.51, indicating a neutral trend. The MACD of -8.10 indicates Negative momentum. The RSI at 50.11 is Neutral, neither overbought nor oversold. The STOCH value of 68.51 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for JP:3154.

Medius Holdings Co., Ltd. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
4556	84 Outperform	¥5.24B	8.47		2.51%	5.38%	-7.04%
7980	73 Outperform	¥5.77B	8.66		1.85%	5.45%	0.23%
7743	67 Neutral	¥16.80B	15.07		2.70%	2.38%	-48.68%
7979	67 Neutral	¥68.58B	16.86		2.54%	6.82%	-1.08%
3154	60 Neutral	¥18.79B	13.65		2.35%	11.12%	20.54%
7702	60 Neutral	¥10.99B	124.68		3.76%	3.36%	-310.49%
Sector *	51 Neutral	$7.92B	-0.43	-41.67%	2.21%	22.29%	-1.85%

Medius Holdings Co., Ltd. Corporate Events

Medius Holdings Completes Logistics Division Reorganization

Medius Holdings Co., Ltd. has completed the internal reorganization of its logistics division by transferring it to a wholly owned subsidiary, now renamed Mediris Logistics Co., Ltd. This company split is expected to have an immaterial impact on the company’s overall business results, indicating a strategic move to streamline operations without disrupting financial performance.

Medius Holdings Reports Strong Q3 Financial Growth Amid Strategic Expansion

Medius Holdings Co., Ltd. reported significant financial growth for the third quarter ended March 31, 2025, with net sales increasing by 13.7% and operating profit rising by 22.6% compared to the previous year. The inclusion of two new companies in its consolidation scope reflects Medius Holdings’ strategic expansion, potentially enhancing its market position and offering improved services to stakeholders.